{"title":"EXPRESSION OF CONCERN: COVID-19 re-infection","authors":"","doi":"10.1111/eci.70186","DOIUrl":null,"url":null,"abstract":"<p><b>EXPRESSION OF CONCERN</b>: P. Brouqui, P. Colson, C. Melenotte, L. Houhamdi, M. Bedotto, C. Devaux, P. Gautret, M. Million, P. Parola, D. Stoupan, B. La Scola, J.-C. Lagier, and D. Raoult, “COVID-19 Re-Infection,” <i>European Journal of Clinical Investigation</i> 51, no. 5 (2021): e13537. https://doi.org/10.1111/eci.13537</p><p>This Expression of Concern is for the above article, published online on 6 March 2021 in Wiley Online Library (wiley onlinelibrary.com), and has been issued by agreement between the journal Editor-in-Chief, Fabrizio Montecucco; the European Society for Clinical Investigation; and John Wiley & Sons Ltd. The Expression of Concern has been agreed due to questions raised about the study's adherence to French legal and ethical requirements for research involving human subjects. The investigation into these concerns is ongoing. Therefore, the journal has decided to issue an Expression of Concern to inform and alert readers.</p>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"56 3","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/eci.70186","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Investigation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/eci.70186","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
EXPRESSION OF CONCERN: P. Brouqui, P. Colson, C. Melenotte, L. Houhamdi, M. Bedotto, C. Devaux, P. Gautret, M. Million, P. Parola, D. Stoupan, B. La Scola, J.-C. Lagier, and D. Raoult, “COVID-19 Re-Infection,” European Journal of Clinical Investigation 51, no. 5 (2021): e13537. https://doi.org/10.1111/eci.13537
This Expression of Concern is for the above article, published online on 6 March 2021 in Wiley Online Library (wiley onlinelibrary.com), and has been issued by agreement between the journal Editor-in-Chief, Fabrizio Montecucco; the European Society for Clinical Investigation; and John Wiley & Sons Ltd. The Expression of Concern has been agreed due to questions raised about the study's adherence to French legal and ethical requirements for research involving human subjects. The investigation into these concerns is ongoing. Therefore, the journal has decided to issue an Expression of Concern to inform and alert readers.
关注表达：P. Brouqui， P. Colson， C. Melenotte， L. Houhamdi， M. Bedotto， C. Devaux， P. Gautret， M. Million， P. Parola， D. Stoupan， B. La Scola, j . c。Lagier和D. Raoult，“COVID-19再感染”，欧洲临床研究杂志，第51期。5 (2021): e13537。https://doi.org/10.1111/eci.13537This对上述文章表示关注，该文章于2021年3月6日在线发表在Wiley在线图书馆（Wiley onlinelibrary.com）上，并经期刊主编Fabrizio Montecucco；欧洲临床研究学会；及约翰威利父子有限公司。由于对该研究是否遵守法国涉及人类受试者的法律和道德要求提出了质疑，因此已同意表达关注。对这些问题的调查仍在进行中。因此，该杂志决定发布一份关注表达，以通知和提醒读者。
期刊介绍：
EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
